Relation of Gamma-Glutamyl Transferase to Cardiovascular Events in Patients With Acute Coronary Syndromes

The prognostic value of gamma-glutamyl transferase (GGT) in patients with acute coronary syndromes (ACS) has been incompletely investigated. We investigated this clinically relevant question in 2,534 consecutive patients with ACS who underwent percutaneous coronary intervention (PCI). GGT activity w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2016-05, Vol.117 (9), p.1427-1432
Hauptverfasser:	Ndrepepa, Gjin, MD, Braun, Siegmund, MD, Cassese, Salvatore, MD, Fusaro, Massimiliano, MD, Laugwitz, Karl-Ludwig, MD, Schunkert, Heribert, MD, Kastrati, Adnan, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - enzymology Acute Coronary Syndrome - mortality Acute Coronary Syndrome - therapy Acute coronary syndromes Aged Angina pectoris Cardiovascular Female gamma-Glutamyltransferase - blood Heart attacks Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Male Middle Aged Mortality Percutaneous Coronary Intervention Prognosis Retrospective Studies Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The prognostic value of gamma-glutamyl transferase (GGT) in patients with acute coronary syndromes (ACS) has been incompletely investigated. We investigated this clinically relevant question in 2,534 consecutive patients with ACS who underwent percutaneous coronary intervention (PCI). GGT activity was measured before PCI procedure in all patients. Statin therapy at hospital discharge was prescribed in 94% of the patients. The primary outcome was 3-year mortality. Patients were divided into 3 groups: the group with GGT in the first tertile (GGT
ISSN:	0002-9149 1879-1913
DOI:	10.1016/j.amjcard.2016.02.004